From UBE3A to Angelman syndrome: a substrate perspective

Area of Science:

• Neurogenetics
• Developmental Neuroscience
• Molecular Biology

Background:

• Angelman syndrome (AS) is a severe neurodevelopmental disorder with motor, cognitive, and behavioral symptoms, often including autism spectrum disorder (ASD) features.
• AS is caused by non-functional maternal UBE3A gene, while duplications in the UBE3A region are linked to ASDs.
• Identifying the neural targets (substrates) of UBE3A, an E3 ubiquitin ligase, is a key challenge in AS research.

Purpose of the Study:

• To explore the hypothesis that altered UBE3A protein levels affect substrate proteins, causing AS phenotypes and potentially UBE3A-associated ASDs.
• To investigate the potential molecular overlap between AS and other neurogenetic disorders with overlapping phenotypes.
• To emphasize the critical role of the timing of UBE3A function in AS phenotype development.

Main Methods:

• The study reviews existing literature and hypotheses regarding UBE3A function and its substrates.
• It analyzes the connection between proteins altered in AS and those implicated in other ASDs.
• The research highlights the importance of temporal aspects of UBE3A activity.

Main Results:

• Proteins affected in AS are also linked to other ASDs not previously associated with UBE3A, suggesting a shared molecular basis.
• This overlap implies a potential for unified treatment approaches for neurogenetic disorders with similar phenotypes.
• The timing of UBE3A protein's action is critical for the development of AS phenotypes.

Conclusions:

• Further research is needed to comprehensively identify UBE3A substrates and downstream pathways.
• Understanding the temporal dynamics of UBE3A function and substrate interactions is essential.
• Investigating UBE3A's role may offer insights into a broader range of neurodevelopmental disorders, including ASDs.